Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck KGaA Down-Plays Further Deals After Consumer Health Sell-Off

Executive Summary

The sale of the Merck KGaA consumer health business to Procter & Gamble could eventually give the German multinational greater flexibility in business development activities, but reducing net debt has first claim on the funds.

 

Advertisement

Related Content

Merck KgaA-P&G Deal: Complex In Some Emerging Markets But No ‘Dis-Synergies’
GSK Gains Clarity For Pharma Focus Through Novartis Consumer JV Buy
Deal Watch: Sanofi Begins 2017 By Ending Vaccine JV, Completing Swap With Boehringer

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC122931

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel